Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

275.23
Delayed Data
As of Mar 27
 +0.41 / +0.15%
Today’s Change
205.42
Today|||52-Week Range
307.33
+5.37%
Year-to-Date
Stock Market News for March 24, 2017
Mar 24 / Zacks.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
Mar 22 / Zacks.com - Paid Partner Content
Alkermes Starts Phase III Study to Treat Multiple Sclerosis
Mar 17 / Zacks.com - Paid Partner Content
Five Stocks I Like on the Nasdaq Market
Mar 21 / GuruFocus News - Paid Partner Content
Stock Market News for March 17, 2017
Mar 17 / Zacks.com - Paid Partner Content
3 Biotech Stocks That Are Broker Favorites
Mar 21 / Zacks.com - Paid Partner Content
Trump vows to bring drug prices 'way down'
Mar 07 / CNNMoney.com